134 related articles for article (PubMed ID: 11391604)
21. Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System.
Doornewaard H; van de Seijp H; Woudt JM; van der Graaf Y; van den Tweel JG
Acta Cytol; 1997; 41(1):74-8. PubMed ID: 9022729
[TBL] [Abstract][Full Text] [Related]
22. Digital holographic microscopy as screening tool for cervical cancer preliminary study.
Benzerdjeb N; Garbar C; Camparo P; Sevestre H
Cancer Cytopathol; 2016 Aug; 124(8):573-80. PubMed ID: 27136615
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of cervical cancer screening using visual inspection with acetic acid in Peru.
Luciani S; Munoz S; Gonzales M; Delgado JM; Valcarcel M
Int J Gynaecol Obstet; 2011 Oct; 115(1):53-6. PubMed ID: 21820117
[TBL] [Abstract][Full Text] [Related]
24. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
Wong AK; Chan RC; Nichols WS; Bose S
Cancer; 2009 Feb; 115(4):823-32. PubMed ID: 19127558
[TBL] [Abstract][Full Text] [Related]
25. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
Mango LJ; Valente PT
Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
[TBL] [Abstract][Full Text] [Related]
26. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
Katki HA; Gage JC; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S69-77. PubMed ID: 23519308
[TBL] [Abstract][Full Text] [Related]
27. Cervical screening by neural networks.
Frable WJ
Cancer; 2001 Jun; 93(3):171-2. PubMed ID: 11391603
[No Abstract] [Full Text] [Related]
28. The development of the referral outcome diagram and an analysis of laboratory cancer detection rates in the English NHS cervical screening programme--is there an optimum level of detection of CIN 1 and CIN 2 lesions?
Blanks RG
Cytopathology; 2008 Aug; 19(4):244-53. PubMed ID: 18476989
[TBL] [Abstract][Full Text] [Related]
29. Cytologic predictors of cervical intraepithelial neoplasia in women with an ASCUS Pap smear.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
Acta Cytol; 2000; 44(4):576-86. PubMed ID: 10934951
[TBL] [Abstract][Full Text] [Related]
30. Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women-A cohort study.
Westre B; Giske A; Guttormsen H; Wergeland Sørbye S; Skjeldestad FE
PLoS One; 2019; 14(11):e0221546. PubMed ID: 31689301
[TBL] [Abstract][Full Text] [Related]
31. Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.
Ivanov MK; Titov SE; Glushkov SA; Dzyubenko VV; Malek AV; Arkhangelskaya PA; Samsonov RB; Mikhetko AA; Bakhidze EV; Berlev IV; Kolesnikov NN
Oncol Rep; 2018 Mar; 39(3):1099-1111. PubMed ID: 29328473
[TBL] [Abstract][Full Text] [Related]
32. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
33. Clinical management of abnormal cytology test results and costs associated with the prevention of cervical cancer in Spain.
Blade A; Cararach M; Castro M; Catalá-López F; Pérez-Escolano I; de Sanjosé S
J Low Genit Tract Dis; 2010 Oct; 14(4):311-8. PubMed ID: 20885158
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
35. The risk of false-positive histology according to the reason for colposcopy referral in cervical cancer screening: a blind revision of all histologic lesions found in the NTCC trial.
Dalla Palma P; Giorgi Rossi P; Collina G; Buccoliero AM; Ghiringhello B; Lestani M; Onnis G; Aldovini D; Galanti G; Casadei G; Aldi M; Gomes V; Giubilato P; Ronco G;
Am J Clin Pathol; 2008 Jan; 129(1):75-80. PubMed ID: 18089491
[TBL] [Abstract][Full Text] [Related]
36. Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women.
Lehtovirta P; Paavonen J; Heikinheimo O
Int J STD AIDS; 2008 Jan; 19(1):37-41. PubMed ID: 18275645
[TBL] [Abstract][Full Text] [Related]
37. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of liquid-based Pap tests: comparison of concurrent liquid-based tests and cervical biopsies on 782 women with previously abnormal Pap smears.
Guo M; Hu L; Martin L; Liu S; Baliga M; Hughson MD
Acta Cytol; 2005; 49(2):132-8. PubMed ID: 15839615
[TBL] [Abstract][Full Text] [Related]
39. Mild cervical intraepithelial neoplasia (CIN 1): a histological overdiagnosis.
Al-Nafussi AI; Colquhoun MK
Histopathology; 1990 Dec; 17(6):557-61. PubMed ID: 2076888
[TBL] [Abstract][Full Text] [Related]
40. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
